
Applied Genetic Technologies Corporation AGTC
Quartalsbericht 2022-Q3
hinzugefügt 21.11.2022
Applied Genetic Technologies Corporation P/S 2011-2026 | AGTC
P/S Jährlich Applied Genetic Technologies Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 65.5 | 43 | 1.7 | 3.05 | 2.15 | 5.65 | 125 | 53.3 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 125 | 1.7 | 37.5 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Heron Therapeutics
HRTX
|
1.28 | $ 0.79 | 1.9 % | $ 132 M | ||
|
Altimmune
ALT
|
7.76 K | $ 3.44 | 2.99 % | $ 303 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 218.03 | -1.74 % | $ 5 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Incyte Corporation
INCY
|
3.79 | $ 90.43 | -0.21 % | $ 17.7 B | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Inovio Pharmaceuticals
INO
|
265 | $ 1.54 | -2.41 % | $ 34.1 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Cullinan Management
CGEM
|
35.1 | $ 13.57 | 7.1 % | $ 818 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Inventiva S.A.
IVA
|
128 | $ 6.07 | 4.97 % | $ 138 M | ||
|
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K | ||
|
Cara Therapeutics
CARA
|
2.58 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
KalVista Pharmaceuticals
KALV
|
11.4 | $ 16.82 | -1.06 % | $ 835 M | ||
|
Checkpoint Therapeutics
CKPT
|
3.91 K | - | - | $ 169 M | ||
|
Clovis Oncology
CLVS
|
1.55 | - | -7.23 % | $ 13 M | ||
|
Kamada Ltd.
KMDA
|
2.61 | $ 8.27 | 0.24 % | $ 260 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.13 | 1.67 % | $ 199 M | ||
|
Karyopharm Therapeutics
KPTI
|
0.000503 | $ 7.11 | -6.82 % | $ 866 K | ||
|
Denali Therapeutics
DNLI
|
7.68 | $ 20.99 | 4.07 % | $ 3.45 B | ||
|
Keros Therapeutics
KROS
|
2.1 | $ 11.16 | 1.82 % | $ 415 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
24.5 | $ 4.35 | 2.48 % | $ 722 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
130 | - | -5.98 % | $ 34.1 M |